MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $0.74 | Prev. Close $0.75 | Circuit Range N/A |
Day Range $0.73 - $0.76 | Year Range $0.65 - $2.96 | Volume 12,559 |
Average Traded $0.74 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $0.74 | $0.75 | +4.45% |
07-Apr-26 | $0.70 | $0.72 | +0.56% |
06-Apr-26 | $0.75 | $0.71 | -4.54% |
02-Apr-26 | $0.73 | $0.75 | +0.94% |
01-Apr-26 | $0.70 | $0.74 | +5.40% |
31-Mar-26 | $0.67 | $0.70 | +4.30% |
30-Mar-26 | $0.67 | $0.68 | -0.74% |